Orpea S.A.
ORRRY · Other OTC · USD
0,30USD
−0,3072 (−50,59 %)Stand 24. Aug., 17:16
Kennzahlen
- Eröffnung
- 0,30
- Vortag
- 0,6072
- Tagesspanne
- 0,30 – 0,30
- 52 Wochen
- 0,30 – 7,00
- Volumen
- 100
- Ø Volumen
- 1
- Börsenwert
- 371,54 Mio. $
- KGV
- 0,0
- Gewinn je Aktie (TTM)
- -2.341,43
- Dividendenrendite
- 1,9 %
- Beta
- 0,8
- Nächste Zahlen
- –
Finanzen
| EUR | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Umsatz | 5,2 Mrd. | 4,68 Mrd. | 4,3 Mrd. | 3,92 Mrd. | 3,74 Mrd. |
| Herstellungskosten | 5,21 Mrd. | 4,77 Mrd. | 4,02 Mrd. | 3,46 Mrd. | 3,14 Mrd. |
| Bruttogewinn | −11,33 Mio. | −91,39 Mio. | 277,71 Mio. | 459,68 Mio. | 597,81 Mio. |
| Forschung und Entwicklung | 0 | 0 | 0 | 0 | 0 |
| Vertrieb und Verwaltung | 149,78 Mio. | 39,31 Mio. | 193 Mio. | 6,29 Mio. | 12,51 Mio. |
| Operatives Ergebnis | 5,2 Mrd. | −664,29 Mio. | 364,61 Mio. | 426,42 Mio. | 502,85 Mio. |
| EBITDA | 2,65 Mrd. | −3,45 Mrd. | 958,71 Mio. | 948,59 Mio. | 955,74 Mio. |
| Nettogewinn | 1,35 Mrd. | −4,03 Mrd. | 65,19 Mio. | 160,05 Mio. | 233,99 Mio. |
| Gewinn je Aktie (verwässert) | 652,97 | -3.116,52 | 47,68 | 117,17 | 174,72 |
Bewertung
Letzte 12 Monate
- KGV
- 0,0
- Kurs-Umsatz-Verhältnis
- 0,1
- Kurs-Buchwert-Verhältnis
- 0,0
- PEG
- 0,0
- Bruttomarge
- −0,2 %
- Operative Marge
- 100,0 %
- Nettomarge
- 26,1 %
- Verschuldungsgrad
- 4,9
- EV/EBITDA
- 3,3
- Eigenkapitalrendite
- 703,8 %
- Kapitalrendite (ROIC)
- 41,1 %
- Free-Cashflow-Rendite
- −26,9 %
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | |
|---|---|---|---|---|---|
| Bruttomarge | −0,2 % | −2,0 % | 6,5 % | 11,7 % | 16,0 % |
| Operative Marge | 100,0 % | −14,2 % | 8,5 % | 10,9 % | 13,4 % |
| Nettomarge | 26,1 % | −86,0 % | 1,5 % | 4,1 % | 6,3 % |
| KGV | 0,0 | -0,0 | 0,4 | 0,2 | 0,1 |
| Kurs-Umsatz-Verhältnis | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Kurs-Buchwert-Verhältnis | 0,0 | -0,0 | 0,0 | 0,0 | 0,0 |
| Verschuldungsgrad | 4,9 | -8,9 | 5,2 | 3,0 | 2,9 |
| Liquidität 3. Grades | 0,6 | 0,2 | 0,7 | 0,7 | 1,0 |
| Dividendenrendite | 1,9 % | 0,0 % | 227,3 % | 0,0 % | 249,9 % |
| Unternehmenswert | 8,52 Mrd. | 12,53 Mrd. | 11,2 Mrd. | 9,67 Mrd. | 8,07 Mrd. |
| EV/EBITDA | 3,2 | -3,6 | 11,7 | 10,2 | 8,4 |
| Eigenkapitalrendite | 71,8 % | 268,2 % | 2,8 % | 4,6 % | 7,8 % |
| Kapitalrendite (ROIC) | 41,1 % | −4,4 % | 1,5 % | 2,0 % | 2,6 % |
| Free-Cashflow-Rendite | −20.842,4 % | 13.000,7 % | −2.019,9 % | −457,4 % | −84,4 % |
Wachstum
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | |
|---|---|---|---|---|---|
| Umsatz | +11,0 % | +8,9 % | +9,6 % | +4,9 % | +9,4 % |
| Bruttogewinn | +87,6 % | −132,9 % | −39,6 % | −23,1 % | −14,8 % |
| Operatives Ergebnis | +882,5 % | −282,2 % | −14,5 % | −15,2 % | +17,6 % |
| Nettogewinn | +133,6 % | −6.277,9 % | −59,3 % | −31,6 % | +6,2 % |
| Gewinn je Aktie | +121,0 % | −6.636,3 % | −59,3 % | −32,9 % | +2,4 % |
| Freier Cashflow | −136,0 % | +148,6 % | −296,7 % | −397,4 % | −117,4 % |
| Dividende je Aktie | 0,0 % | −100,0 % | 0,0 % | −100,0 % | +7,5 % |
Analysten
Einstufungen
Gerade nicht verfügbar.
Kursziel
Gerade nicht verfügbar.
Quartalszahlen
| Gewinn je Aktie · Erwartet |
|---|
| Gewinn je Aktie · Tatsächlich |
| Abweichung |
| Umsatz · Tatsächlich |
Dividenden und Splits
| Ex-Tag | Zahltag | Betrag |
|---|---|---|
| 15. Dez. 2023 | 26. Dez. 2023 | 0,01 |
| 23. Juli 2021 | 2. Aug. 2021 | 0,21 |
Aktiensplits
–
Eigentümer
Institutionen
Gerade nicht verfügbar.
Insider-Geschäfte
–
Vergleichbare Unternehmen
Über das Unternehmen
ORPEA S.A. is a healthcare provider that manages and operates various types of facilities, including senior living communities, post-acute and rehabilitative hospitals, and psychiatric care centers. Within its senior living and assisted care residences, ORPEA offers individualized support. These facilities also provide comprehensive residential services such as accommodation, meals, laundry, and housekeeping, complemented by a diverse array of daily events, entertainment, and therapeutic programs. Its post-acute and rehabilitation hospitals specialize in recovery for various conditions, encompassing geriatrics, musculoskeletal and nervous system disorders, cardiovascular and hematological issues, oncology, and advanced care for individuals in persistent vegetative or minimally conscious states. ORPEA's psychiatric hospitals offer comprehensive care for a wide array of mental health challenges. These include mood, anxiety, obsessive-compulsive, addiction, eating, sleep, and personality disorders, as well as age-related psychiatric conditions, psychosis, burnout, chronic fatigue syndrome, fibromyalgia, psychosomatic conditions, and post-traumatic stress disorder. They serve various patient demographics, from geriatric to child and young adult populations, alongside parent-child and public/private client groups. Furthermore, the company extends its services to home care, encompassing domestic assistance (like cleaning, meal preparation, ironing, gardening, and errands), daily life support (including day/night supervision, hygiene aid, and mealtime assistance), and mobility support. The company maintains a substantial international presence, operating facilities across numerous countries in Europe, Latin America, and Asia, including France, Belgium, Spain, Italy, Ireland, Switzerland, Austria, Germany, the Czech Republic, Poland, the Netherlands, Luxembourg, Portugal, Brazil, Russia, Slovenia, Uruguay, Colombia, Mexico, Chile, Latvia, Croatia, and China. Established in 1989, ORPEA S.A. has its headquarters in Puteaux, France.
Führung
- Laurent GuillotChief Executive Officer & Director
- Benoit LesieurInvestor Relations Director
- Linda BenattarPresident of the Group Medical Committee
- Bertrand DesriauxExecutive Vice President of Human Resources
- Emmanuel MassonExecutive Vice President of Expansion & Network Development
- Laurent LemaireGroup Executive Vice President of Finance, Procurement & Information Systems
- CEO
- Laurent Guillot
- Mitarbeitende
- 76.000
- Hauptsitz
- Puteaux, FR
- Sektor
- Healthcare
- Branche
- Medical - Care Facilities
- Börsengang
- 18. Dez. 2020
- Website
- orpea-corp.com
Nachrichten
Gerade keine Nachrichten zu diesem Unternehmen.
Kurse mindestens 15 Minuten verzögert. Daten: Financial Modeling Prep. Keine Anlageberatung.